Abstract: Methods and systems for training a summarization neural network through reinforcement learning. As part of the training, entity context data for a particular entity can be received. A ground truth label for a downstream prediction task for the particular entity can be received. The entity context data can be processed using a summarization neural network to generate a summary of the entity context data. A predicted output for the downstream prediction task can be generated from the summary of the entity context data. A reward can be determined from the predicted output and the ground truth label. Then, the summarization neural network can be trained using the reward through reinforcement learning.

Abstract: A memory device includes: a first array of memory cells; a second array of tracking cells, the second array being configured to emulate the first array; a first word line coupled to corresponding ones of the memory cells in a corresponding one of rows of the first array and to the tracking cells; a second word line configured to emulate the first word line; a first adjust circuit coupled to the first word line; a second adjust circuit coupled to the second word line; and an adjust-timing circuit coupled to the second adjust circuit.

Abstract: A memory circuit includes a first and second inverter, and a level shifter circuit. The first inverter is coupled to a first voltage supply, and configured to generate a first input signal in response to a second input signal. The level shifter circuit is coupled to a second voltage supply, and configured generate a first and second signal responsive to a first or second input signal. The second inverter is configured to generate a word line signal in response to the first signal. The level shifter circuit is configured to delay a leading edge of the word line signal in response to the first or second signal. An amount of delay of the leading edge of the word line signal is based on a voltage difference between the first and second supply voltage. The first supply voltage has a first swing. The second supply voltage has a second swing.

Abstract: The present invention discloses an outdoor sunshade umbrella with an umbrella column lifting structure, including an umbrella column assembly and an umbrella frame assembly. The umbrella column assembly includes an upper umbrella column and a lower umbrella column. The upper umbrella column and the lower umbrella column are in sliding fit and have a lifting adjustment mechanism arranged therebetween. The lifting adjustment mechanism is configured to implement ascending or descending of the upper umbrella column relative to the lower umbrella column and can be locked at any height. The umbrella frame assembly is mounted on the upper umbrella column and can be ascended or descended under driving of the upper umbrella column. According to the present invention, the umbrella column assembly is divided into the upper umbrella column and the lower umbrella column that are in sliding fit and have the lifting adjustment mechanism arranged therebetween.

Abstract: A method and an apparatus for generating and displaying a latent image, a storage medium, and an electronic device are provided.

Abstract: The present application discloses an integrated aroma diffuser comprising a liftable aroma diffuser body slidably disposed within a guide sleeve and a lifting drive mechanism configured to drive the liftable aroma diffuser body to move vertically relative to the guide sleeve. The lifting drive mechanism achieves vertical motion of the liftable aroma diffuser body through the engagement of a gear and a rack, such that the body is sleeved within and slides up and down relative to the guide sleeve. When the liftable aroma diffuser body ascends a certain distance relative to the guide sleeve, internal components such as the essential oil bottle are exposed, thereby facilitating convenient replacement of the essential oil bottle.

Abstract: Aspects of the disclosure relate to compositions and methods for expressing a Factor H protein (or a variant thereof) in a cell or subject. In some embodiments, the disclosure provides isolated nucleic acids and rAAVs comprising a transgene encoding a Factor H protein variant and one or more regulatory sequences. In some embodiments, compositions described herein are useful for treating subjects having diseases associated with Factor H deficiency.

Abstract: The present disclosure relates to obstacle detection methods, apparatuses, systems, and computing devices. One example method includes obtaining an image, then constructing a depth map of the image based on structure constraint information, and after completing depth map construction, processing the depth map to obtain a region identifier map including a plurality of regions, where each of the plurality of regions is a traveling region or a non-traveling region. The structure constraint information includes a semantic type of each sample in the image, and the non-traveling region is considered as an obstacle.

Abstract: Provided is a tail water treatment and recycling system for aquaculture configured to identify the overall water body inside the aquaculture pond to determine the distribution status information of tail water within the pond. It also performs non-contact scanning detection on the water body inside the sedimentation tank, analyzes the sedimentation movement data of sediments within the tank, and evaluates this data to ensure maximum sediment settlement. Furthermore, it determines the reaction progress information inside the decomposition tank, and subsequently adjusts the environmental conditions for decomposition reactions within the tank, effectively reducing the nutrient concentration in the tail water. According to the oxygen content of the water body in the pond, it also adjusts the oxygenation operation for the tail water that has undergone decomposition, ensuring that the pond can continuously and stably receive a supply of clean, high-oxygen recycled water.

Abstract: Embodiments of the present disclosure disclose a method and apparatus for controlling a smart home device, an electronic device, a medium, and a product. The method includes determining a smart home device that is associated with an environmental factor to be controlled; generating a query associated with the smart home device based on a current state of the environmental factor to be controlled; inputting the query into a large language model; obtaining a reply generated based on the query from the large language model; converting the reply from the large language model into a control instruction for the smart home device; and controlling the smart home device based on the control instruction.

Abstract: Aspects of the disclosure relate to compositions and methods for modulating bone growth, for example by increasing osteogenesis and/or decreasing osteoclastogenesis. The disclosure is based, in part, on recombinant adeno-associated virus (rAAV) vectors encoding microRNAs or miRNA inhibitors that inhibit endogenous miR-214-3p and/or mediate overexpression of miR-34a-5p in osteoblasts and osteoclasts. In some embodiments, compositions described by the disclosure are useful for treating certain bone diseases or disorders, such as osteoporosis.

Abstract: Embodiments of the disclosure encompass methods and compositions related to treatment for individuals that have bile duct paucity, such as individuals with Alagille Syndrome. The methods and compositions relate to use of inhibitory agents that target SOX4 expression to reduce it or that target SOX4 or to reduce its activity. Specific embodiments include AAV8 vectors that encode an shRNA that targets SOX4.

Abstract: Disclosed are a rubber asphalt-derived volatile organic compounds (VOCs) inhibitor based on a metal organic frameworks (MOFs) material and a preparation method thereof, and a smoke-suppression rubber asphalt and a preparation method thereof. The inhibitor has a chemical formula of CxHyO32Zr6, where x is in a range of 48 to 120, and y is in a range of 28 to 76; and the inhibitor is a zirconium-based MOFs material having a cubic crystal structure with a crystal pore size of 0.5 nm to 2 nm and a specific surface area of 1,000 m2/g to 3,200 m2/g.

Abstract: A semiconductor device includes: a first array of memory cells; a second array of tracking cells, the second array being configured to emulate the first array; a first word line coupled to corresponding ones of the memory cells in a corresponding one of rows of the first array and to the tracking cells; a second word line configured to emulate the first word line; a first adjust circuit coupled to the first word line; and a second adjust circuit coupled to the second word line.

Abstract: Aspects of the disclosure relate to compositions and methods for treating spinal muscular atrophy (SMA). The disclosure is based, in part, on isolated nucleic acids and vectors (e.g., viral vectors, such as rAAV vectors) encoding SMN1. In some embodiments, the expression of SMN1 is driven by a native SMN1 promoter or a variant thereof. In some embodiments, isolated nucleic acids and vectors of the disclosure have reduced toxicity and/or increased transgene expression relative to previously described SMN-encoding vectors.

Abstract: A method of preparing lithium nickel manganese cobalt oxide high-nickel single-crystal positive electrode material comprises the following steps: mixing and ball milling nickel cobalt manganese hydroxide with a lithium source, zirconium oxide, tungsten oxide, and sodium carbonate, then performing primary sintering, pulverizing, and then obtaining an lithium nickel manganese cobalt oxide high-nickel single-crystal positive electrode material intermediate, the temperature of the primary sintering being 50-150° C. higher than a normal sintering temperature; and evenly mixing the lithium nickel manganese cobalt oxide high-nickel single-crystal positive electrode material intermediate and a coating agent, and then performing secondary sintering to obtain the lithium nickel manganese cobalt oxide high-nickel single-crystal positive electrode material.

Abstract: A circuit includes a memory circuit, and a power management circuit having a latch circuit. The latch circuit, in response to a first state of a first management signal, controls supply of a first supply voltage to the memory circuit in accordance with a control signal. The latch circuit, in response to a second state of the first management signal, stores a state of the control signal, and controls supply of the first supply voltage in accordance with the stored state. The power management circuit, in response to a second management signal, disables at least one interface circuit in at least one of the power management circuit or the memory circuit. The at least one interface circuit interfaces between a first power domain of a first power supply voltage corresponding to the first supply voltage, and a second power domain of a different second power supply voltage.

Abstract: In some aspects, the disclosure relates to methods for improving titer and yield of viral vector production. In some embodiments, the methods comprise transient silencing of transgene expression during packaging of a viral vector.

Abstract: A memory circuit includes a first and second inverter, a level shifter circuit, a memory cell configured to receive a word line signal, and a local input/output (LIO) circuit. The first inverter is coupled to a first voltage supply, and configured to generate a first input signal in response to a second input signal. The level shifter circuit is coupled to a second voltage supply, and configured generate a first and second signal responsive to a first or second input signal. The second inverter is configured to generate the word line signal in response to the first signal. The level shifter circuit is configured to delay a leading edge of the word line signal in response to the first or second signal. An amount of delay of the leading edge of the word line signal is based on a voltage difference between the first and second supply voltage.

Abstract: In some aspects the disclosure relates to recombinant adeno-associated virus (rAAV) vectors and rAAVs (e.g., viral particles) engineered to express a transgene comprising an inhibitory nucleic acid (e.g., an artificial miRNA, amiRNA) having a pri-miRNA scaffold and a guide strand that targets a human target gene.